Search by Drug Name or NDC

    NDC 72189-0167-30 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5; 100 mg/1; mg/1 Details

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5; 100 mg/1; mg/1

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM.

    Product Information

    NDC 72189-0167
    Product ID 72189-167_ff328439-b70e-9387-e053-6294a90a45cb
    Associated GPIs 36994002450325
    GCN Sequence Number 059919
    GCN Sequence Number Description losartan/hydrochlorothiazide TABLET 100-12.5MG ORAL
    HIC3 A4I
    HIC3 Description ANGIOTENSIN RECEPTOR ANTAG.-THIAZIDE DIURETIC COMB
    GCN 25851
    HICL Sequence Number 009863
    HICL Sequence Number Description LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 100
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
    Labeler Name Direct_Rx
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078245
    Listing Certified Through 2024-12-31

    Package

    NDC 72189-0167-30 (72189016730)

    NDC Package Code 72189-167-30
    Billing NDC 72189016730
    Package 30 TABLET in 1 BOTTLE (72189-167-30)
    Marketing Start Date 2021-01-08
    NDC Exclude Flag N
    Pricing Information N/A